ArticleSignal transduction and targeted therapy2020

A CRISPR knockout negative screen reveals synergy between CDKs inhibitor and metformin in the treatment of human cancer in vitro and in vivo.

Yarui Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.